INSIDER TRADING

SOPHiA GENETICS SA CEO Ross Muken buys $137,188 of SOPH

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
SOPHiA GENETICS SA CEO Ross Muken buys $137,188 of SOPH

The CEO paid an average of $6.86 a share, according to a Form 4 filed with the SEC on Nov 9. Information only, not investment advice.

SOPHiA GENETICS SA's chief executive officer, Ross Muken, bought 20,000 shares of the company's stock on the open market on Nov 6. The purchase, at an average of $6.86 a share, comes to about $140,000.

It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. The filing came 3 days after the trade.

After the trade, the filing lists 680,391 shares held.

The numbers below are taken from the Form 4 as filed with the SEC.

The purchase
CompanySOPHiA GENETICS SA (SOPH)
InsiderRoss Muken
RoleCEO
TransactionOpen-market purchase (code P)
Shares20,000
Average price$6.86
Value$137,188
Trade dateNov 6, 2026
Filed with the SECNov 9, 2026, 4:05 PM ET
Shares held after680,391
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

See the detailed report on this SOPH purchase

View the Form 4 on SEC.gov

Browse the latest insider buying · Follow SOPH for the next insider trade

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.